EP Patent

EP2870169A1 — Process for preparing diastereomerically enriched phosphoramidate derivatives of nucleoside compounds for treatment of viral infections

Assigned to Bristol Myers Squibb Co · Expires 2015-05-13 · 11y expired

What this patent protects

The present invention is directed to a process for preparing diastereomerically enriched nucleoside phosphoramidates having the formula I:

USPTO Abstract

The present invention is directed to a process for preparing diastereomerically enriched nucleoside phosphoramidates having the formula I:

Drugs covered by this patent

Patent Metadata

Patent number: EP2870169A1
Jurisdiction: EP
Classification: —
Expires: 2015-05-13
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.